Filing Details

Accession Number:
0001765581-22-000104
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-17 16:41:39
Reporting Period:
2022-08-15
Accepted Time:
2022-08-17 16:41:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1784606 Patricia Carr 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Svp, Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2022-08-15 142 $156.86 5,934 No 4 S Direct
Ordinary Shares Acquisiton 2022-08-15 2,000 $113.10 7,934 No 4 M Direct
Ordinary Shares Disposition 2022-08-15 2,000 $160.29 5,934 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Non-Qualified Stock Option (right to buy) Disposition 2022-08-15 2,000 $0.00 2,000 $113.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,500 2030-02-26 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.